A short local news segment on a study that researchers say points to GLP-1 drugs possibly slowing the aging process. Details are thin, so check the source.
Recap by typeshit. Full story at WSMV.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
People on GLP-1 medicines reported nail issues, including nails separating from the skin, more often than non-users in a new survey.
NexLife put out a monthly index tracking what online sellers charge for compounded GLP-1 drugs. Only the announcement title is available so far.
Loading…